These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 839648
1. [Studies on tuberactinomycin-N. Report 3. Comparison of the effects of TUM-N and INH on experimental mouse tuberculosis (author's transl)]. Shimizu T, Yokoyama M, Yoshida U, Onuma H, Narita A. Kekkaku; 1977 Jan; 52(1):21-7. PubMed ID: 839648 [No Abstract] [Full Text] [Related]
3. Experimental and clinical study on the antituberculous activity of tuberactinomycin-N, a new antibiotic. Toyoara M. Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():288-91. PubMed ID: 4468026 [No Abstract] [Full Text] [Related]
4. [Experimental studies in vitro on the antituberculous activities of tuberactinomycin (TUM) and tuberactinomycin-N (TUM-N) (author's transl)]. Maekawa N, Ikeda N, Oda Y, Uratsuji Y, Inagake H. Kekkaku; 1977 May; 52(5):211-8. PubMed ID: 407391 [No Abstract] [Full Text] [Related]
10. [Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)]. Tsukamura M, Mizuno S, Murata H, Oshima T. Kekkaku; 1975 May; 50(4-5):123-30. PubMed ID: 49449 [No Abstract] [Full Text] [Related]
11. [Clinical study on tuberactinomycin-N (TUM-N) and viomycin (VM) in retreatment of pulmonary tuberculosis (author's transl)]. Kekkaku; 1974 Jul; 49(7):207-15. PubMed ID: 4372439 [No Abstract] [Full Text] [Related]
12. [Comparative studies on therapeutic effect of rifampicin and isoniazid on experimental mouse tuberculosis (author's transl)]. Kondo E, Kanai K. Kekkaku; 1978 Apr; 53(4):261-4. PubMed ID: 661058 [No Abstract] [Full Text] [Related]
13. [Basic studies on viomycin and tuberactinomycin (author's transl)]. Aoyagi T, Kawai T, Yamada Y, Fujino T, Kaneko K. Kekkaku; 1975 Oct; 50(10):295-301. PubMed ID: 175205 [No Abstract] [Full Text] [Related]
18. [Side effect of enviomycin as the causative agent of the changes in serum electrolytes (author's transl)]. Aizawa H, Hayashi H, Yamamoto N. Kekkaku; 1980 Jan; 55(1):1-5. PubMed ID: 7366064 [No Abstract] [Full Text] [Related]
20. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis. Gao XF, Wang L, Liu GJ, Wen J, Sun X, Xie Y, Li YP. Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199 [Abstract] [Full Text] [Related] Page: [Next] [New Search]